Cytori Therapeutics, Inc. (CYTX) Reports Nine Month and Third Quarter 2013 Business and Financial Results
11/8/2013 7:42:32 AM
Cytori Therapeutics (NASDAQ: CYTX) today reports its nine month and third quarter 2013 financial results and provides updates on clinical development, commercialization and corporate development activities.
Total revenue for the nine months and quarter ended September 30, 2013 were $8.7 million and $2.7 million, respectively. Net loss for the nine months and quarter ended September 30, 2013 was $16.1 million and $5.3 million, respectively.
Help employers find you! Check out all the jobs and post your resume.
comments powered by